Cerebrospinal fluid A beta 42 is the best predictor of clinical progression in patients with subjective complaints

Argonde C. van Harten*, Pieter Jelle Visser, Yolande A. L. Pijnenburg, Charlotte E. Teunissen, Marinus A. Blankenstein, Philip Scheltens, Wiesje M. van der Flier

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)481-487
JournalAlzheimer's & Dementia
Volume9
Issue number5
DOIs
Publication statusPublished - Sep 2013

Keywords

  • Subjective complaints
  • Biomarkers
  • Cerebrospinal fluid
  • Alzheimer's disease
  • Clinical progression
  • Predictive value

Cite this